If you are interrupted, or if you need to cough or rest during administration, turn off the compressor to avoid wasting the medication.
Turn the compressor back on when you are ready to resume treatment. Omit this dose if your next dose is due in less than 6 hours.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Some side effects can be serious
If you experience any of the following side effects, stop using Tobramicina andinform your doctor immediately:
If you experience any of the following side effects,inform your doctor immediately:
Your underlying lung disease may worsen while you are using Tobramicina. This may be due to lack of effectiveness. Inform your doctor immediately if this occurs.
Some side effects are very common
These side effects can affect more than 1 in 10 people.
If any of them affect you severely,inform your doctor.
Some side effects are common
These side effects can affect up to 1 in 10 people.
If any of them affect you severely,inform your doctor.
Other side effects:
If any of them affect you severely,inform your doctor.
If you have received Tobramicina at the same time or after repeated cycles of tobramycin or other aminoglycoside antibiotics, hearing loss has been reported as a side effect.
Tobramycin injections or other aminoglycosides may cause allergic reactions, hearing problems, and kidney problems.
Patients with cystic fibrosis may experience several symptoms characteristic of the disease. These may even occur while taking Tobramicina but should not be more frequent or appear worse than before treatment.
Reporting side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is a possibleside effect that does not appear in this prospectus.You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use (www.notificaRAM.es). By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Never store an open ampule. Once an ampule is opened, it must be used immediately and any remaining product must be discarded.
Composition of Tobramicina Altan
Appearance of the product and contents of the packagingTobramicina Altan is a transparent, slightly yellow solution that is presented in a ready-to-use ampoule.
The ampoules are packaged in aluminum bags, one aluminum bag contains 7 ampoules that correspond to 7 days of treatment.
Tobramicina Altan is available in packaging of 56 ampoules, which are sufficient for a treatment cycle.
It may be that not all packaging sizes are marketed.
Holder of the marketing authorization:
Altan Pharmaceuticals, S.A.
C/ Cólquide, Nº 6, Portal 2, 1st Floor, Office F.
Edificio Prisma,
Las Rozas, 28230 Madrid
Responsible for manufacturing:
Altan Pharmaceuticals, S.A.
Polígono Industrial de Bernedo, s/n
01118 Bernedo (Álava)
Spain
Altan Pharmaceuticals, S.A.
Avda. de la Constitución, 198-199
Polígono Industrial Monte Boyal, Casarrubios del Monte, 45950 Toledo
Spain
This medicine is authorized in the following member states of the EU with the following names:
France: Tobramycine Zentiva 300 mg/5 ml Solution for inhalation by nebulizer
Germany: Tobramycin Zentiva 300 mg/ 5 ml Solution for a nebulizer
Italy: Tobramicina Altan 300 mg/5 ml solution for nebulizer
Portugal: Tobramicina Altan. 300 mg/ 5 ml Solution for Inhalation by Nebulization
Spain: Tobramicina Altan. 300 mg/ 5 ml Solution for inhalation by nebulizer
United Kingdom: Tobramycin 300 mg/ 5 ml Nebuliser solution
Last review date of this leaflet: October 2023
Other sources of information
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/”
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.